Archives
-
Angiotensin II: Mechanism and Research Workflow
2026-09-21
Angiotensin II is the octapeptide Asp-Arg-Val-Tyr-Ile-His-Pro-Phe and a potent vasopressor that activates angiotensin GPCRs. This article connects receptor signaling with hypertension mechanism study, vascular smooth muscle cell hypertrophy research, cardiovascular remodeling investigation, and abdominal aortic aneurysm model design.
-
Toremifene Citrate: Applied ER Research Workflows
2026-09-21
Build more interpretable estrogen-receptor assays with Toremifene Citrate, from receptor binding and dose-response studies to breast cancer cell phenotyping. This practical guide connects concentration selection, controls, formulation, and troubleshooting with clinically relevant pharmacology.
-
BI-1347 Inhibitor: CDK8/19 Research Guide
2026-09-20
BI-1347 is an orally active, selective small-molecule inhibitor reported with an IC50 of 1.1 nM and antitumor activity. This guide separates product specifications from CDK8/19 literature evidence and defines practical boundaries for cancer biology research, signal transduction studies, and molecular target inhibition.
-
Chicken Gasdermins Reveal Caspase-Driven Pyroptosis
2026-09-19
The reference study establishes that chicken GSDMA and GSDME can be activated through distinct caspase-dependent cleavage routes, connecting gasdermin processing with membrane damage, cell death, and antibacterial activity. Its combination of cleavage mapping, cell-based assays, and infection models provides a framework for interpreting pyroptosis research in birds while highlighting limits on direct translation to mammalian systems.
-
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-09-18
Build a rapid two-parameter cell death workflow that separates viable, early apoptotic, late apoptotic, and membrane-compromised populations. Apply the assay to TKI-response studies in Ph+ ALL, then connect phosphatidylserine exposure with mitochondrial and signaling measurements.
-
Hyperthermia, Cisplatin, and Caspase-8 Signaling
2026-09-18
The reference study identifies caspase-8 accumulation and activation as a mechanistic link between hyperthermia–cisplatin treatment, apoptosis, and pyroptosis in cancer cells. Its combination of biochemical, imaging, genetic, and ultrastructural evidence suggests that K63-linked ubiquitination and p62-associated caspase-8 signaling may help explain why hyperthermia increases cisplatin sensitivity.
-
Prochlorperazine-Induced Neuroleptic Malignant Syndrome
2026-09-17
This 2024 case report describes neuroleptic malignant syndrome after standard-dose Prochlorperazine in a 76-year-old man, despite initially unremarkable routine laboratory findings. The report shows why medication history, neurological examination, and serial clinical assessment remain central to recognizing this rare emergency during antiemetic therapy.
-
HyperScript RT SuperMix for qPCR: Assay Design
2026-09-17
HyperScript RT SuperMix for qPCR supports a rational two-step workflow for difficult RNA, including circRNA and low-abundance transcripts. This article translates a recent esophageal cancer study into practical decisions about primer choice, cDNA synthesis, controls, and pathway-level interpretation.
-
Fluoxetine HCl: From Serotonin to Motivation
2026-09-16
A translational perspective on Fluoxetine HCl that connects SERT biology, 5-HT2C receptor pharmacology, neurogenesis and synaptic plasticity studies, and developmental SSRI effects on motivation. The article outlines experimental design principles for depression research while clarifying the boundaries between molecular assays, behavioral phenotyping, and clinical interpretation.
-
Fe3O4@ZIF-8 for Jaw Osteomyelitis
2026-09-16
The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function platform for treating jaw osteomyelitis. Its central innovation is the combination of pH-responsive Zn2+ release for antibacterial activity with Fe3O4-mediated, static-magnetic-field-assisted bone regeneration, addressing infection control and defect repair within one material system.
-
MLKL Polymerization and Lysosomal LMP in Necroptosis
2026-09-15
The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a key execution step in necroptosis. Using live-cell imaging and cathepsin B perturbation in human HT-29 cells, it connects lysosomal damage to cytosolic protease release and downstream loss of cell viability.
-
Electroporation Enables CRISPR Editing in Mouse Zygotes
2026-09-15
Hashimoto and Takemoto showed that electroporation can deliver Cas9 mRNA and guide RNA into mouse zygotes without removing the zona pellucida, offering a scalable alternative to embryo microinjection. Their optimized workflow supported CRISPR/Cas9-mediated gene disruption and ssODN-mediated knock-in, while highlighting the need to balance RNA uptake with embryo survival.
-
Honokiol N1672: Reliable Cell Assays
2026-09-14
Learn how Honokiol (SKU N1672) can support more consistent viability, proliferation, and cytotoxicity workflows through controlled solubilization, fresh preparation, appropriate controls, and careful interpretation of metabolic endpoints. The article connects product specifications with current immunometabolism findings while distinguishing evidence-based guidance from practical laboratory recommendations.
-
Platinum ROS Storm: A Distinct Cancer-Killing Mechanism
2026-09-14
The reference study presents carrier-platin, a poly(amino acid) formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species in cancer cells. Its reported activity is independent of DNA damage and is classified as neither conventional apoptosis nor ferroptosis, suggesting a distinct ROS-driven strategy that may retain activity against multidrug-resistant tumors.
-
Aminopeptidase Selectivity in ACE Inhibitor Studies
2026-09-13
The reference study re-evaluated how bestatin and several metallopeptidase inhibitors act on porcine kidney aminopeptidases A, N, and W. Its central contribution was to show that inhibitor selectivity is enzyme- and chemical-class dependent, providing an important counter-screening framework for interpreting ACE inhibitor experiments.